Guiding postablative lymphocyte reconstitution as a route toward transplantation tolerance

American Journal of Transplantation

Volumn 14, Issue 7, 2014, Pages 1678-1689

  Piotti, G ^a,b   Ma, J ^a   Adams, E ^a   Cobbold, S ^a   Waldmann, H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Campath; homeostatic proliferation; IL 7; rapamycin; transplantation tolerance

Indexed keywords

RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; CD52 ANTIGEN; GLYCOPROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 7 RECEPTOR; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TRANSPLANTATION TOLERANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; CBA MOUSE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MALE; METABOLISM; PHYSIOLOGY; SKIN TRANSPLANTATION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, NEOPLASM; FEMALE; GLYCOPROTEINS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-7; SIROLIMUS; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION TOLERANCE;

EID: 84903173869     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12756     Document Type: Article

References (29)

1. Kirk AD, Hale DA, Mannon RB, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H). Transplantation 2003; 76: 120-129.
2. Neujahr DC, Chen CQ, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632-4639.
3. Moxham VF, Karegli J, Phillips RE, et al. Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol 2008; 180: 3910-3918.
4. Schluns KS, Kieper WC, Jameson SC, Lefrancois L., Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432.
5. Tan JT, Dudl E, LeRoy E, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001; 98: 8732-8737.
6. Bourgeois C, Kassiotis G, Stockinger B., A major role for memory CD4 T cells in the control of lymphopenia-induced proliferation of naive CD4 T cells. J Immunol 2005; 174: 5316-5323.
7. Rocha B, Dautigny N, Pereira P., Peripheral T lymphocytes: Expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur J Immunol 1989; 19: 905-911.
8. Cho BK, Rao VP, Ge Q, Eisen HN, Chen JZ., Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 2000; 192: 549-556.
9. Goldrath AW, Bogatzki LY, Bevan MJ., Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000; 192: 557-564.
10. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465-474.
11. Wu ZH, Bensinger SJ, Zhang JD, et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004; 10: 87-92.
12. Battaglia M, Stabilini A, Roncarolo MG., Rapamycin selectively expands CD4(+)CD25(+)FoxP3(+) regulatory T cells. Blood 2005; 105: 4743-4748.
13. Zeiser R, Leveson-Gower DB, Zambricki EA, et al. Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells. Blood 2008; 111: 453-462.
14. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-1700.
15. Sudo T, Nishikawa S, Ohno N, et al. Expression and function of the interleukin-7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A 1993; 90: 9125-9129.
16. Gilliland LK, Walsh LA, Frewin MR, et al. Elimination of the immunogenicity of therapeutic antibodies. J Immunol 1999; 162: 3663-3671.
17. Waldmann H, Hale G., Campath: From concept to clinic. Philos T Roy Soc B 2005; 360: 1707-1711.
18. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L., Monoclonal-antibodies recognizing transforming growth factor-beta-Bioactivity neutralization and transforming growth-factor beta-2 affinity purification. J Immunol 1989; 142: 1536-1541.
19. Davies JD, Leong LYW, Mellor A, Cobbold SP, Waldmann H., T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602-3607.
20. FlowJO TSI, Ashland Oregon, USA. Proliferation Tutorial. Available at: http://wwwflowjocom/home/tutorials/proliferationhtml. Accessed January 20, 2011.
21. Chen WJ, Jin WW, Hardegen N, et al. Conversion of peripheral CD4(+)CD25(-) naive T cells to CD4(+)CD25(+) regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
22. De Serres SA, Mfarrej BG, Magee CN, et al. Immune profile of pediatric renal transplant recipients following alemtuzumab induction. J Am Soc Nephrol 2012; 23: 174-182.
23. Cox AL, Thompson SAJ, Jones JL, et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol 2005; 35: 3332-3342.
24. Hu YP, Turner MJ, Shields J, et al. Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model. Immunology 2009; 128: 260-270.
25. Graca L, Le Moine A, Lin CY, Fairchild PJ, Cobbold SP, Waldmann H., Donor-specific transplantation tolerance: The paradoxical behavior of CD4(+)CD25(+) T cells. Proc Natl Acad Sci U S A 2004; 101: 10122-10126.
26. Penaranda C, Kuswanto W, Hofmann J, et al. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc Natl Acad Sci U S A 2012; 109: 12668-12673.
27. Wang Y, Dai H, Liu Z, Cheng X, Tellides G, Dai Z., Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade. Am J Transplant 2006; 6: 2851-2860.
28. Halloran PF., Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715-2729.
29. Kendal AR, Chen Y, Regateiro FS, et al. Sustained suppression by Foxp3(+) regulatory T cells is vital for infectious transplantation tolerance. J Exp Med 2011; 208: 2043-2053.